0001225208-21-004697.txt : 20210304 0001225208-21-004697.hdr.sgml : 20210304 20210304160727 ACCESSION NUMBER: 0001225208-21-004697 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210302 FILED AS OF DATE: 20210304 DATE AS OF CHANGE: 20210304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brennan Daniel J. CENTRAL INDEX KEY: 0001595612 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 21714193 MAIL ADDRESS: STREET 1: BOSTON SCIENTIFIC CORPORATION STREET 2: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 4 1 doc4.xml X0306 4 2021-03-02 0000885725 BOSTON SCIENTIFIC CORP BSX 0001595612 Brennan Daniel J. 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 EVP and CFO Common Stock 2021-03-02 4 S 0 9475.0000 38.8426 D 275370.0000 D Common Stock 2021-03-03 4 S 0 12127.0000 38.6886 D 263243.0000 D This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $38.66 to $38.95, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $38.558 to $38.90, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Scott G. Hodgdon, Attorney-in-Fact 2021-03-04